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Objective: To investigate the anti-obesity activity and the action mechanism of the roots
of Adenophora triphylla var. japonica extract (ATE) in high-fat diet (HFD)–induced
obese mice and 3T3-L1 adipocytes.
Methods: The roots of Adenophora triphylla were extracted with 70% ethanol. To
demonstrate the compounds, linoleic acid was analyzed by using gas chromatography;
and the anti-obesity effects and possible mechanisms of ATE were examined in 3T3-L1
adipocytes and HFD-induced obese mice.
Results: Treatment with ATE inhibited the lipid accumulation without cytotoxicity in
3T3-L1 adipocytes. Furthermore, 200 and 400 mg/kg ATE treatment signiﬁcantly
decreased the body weight gain, white adipose tissues (WATs) weight and plasma tri-
glyceride level, while 100 and 200 mg/kg ATE treatment increased the plasma high-
density lipoprotein cholesterol level in the HFD-induced obese mice, as compared with
the HFD group. Treatment with 200 and 400 mg/kg ATE also lowered the size of adi-
pocytes in adipose tissue and reduced the lipid accumulation in liver. ATE treatment
showed signiﬁcantly lower expression level of adipogenesis-related proteins, such as
peroxisome proliferator-activated receptor g, fatty acid binding protein (aP2), fatty acid
synthase in 3T3-L1 adipocytes; and furthermore, decreased peroxisome proliferator-
activated receptor g, aP2, fatty acid synthase, sterol regulatory element binding
protein-1c, and lipoprotein lipase mRNA expression levels in WAT of the HFD-induced
obese mice.
Conclusions: These results suggested that the ATE has an anti-obesity effect, which may
be elicited by regulating the expression of adipogenesis and lipogenesis-related genes and
proteins in adipocytes and WAT of the HFD-induced obese mice.sity, Cheoin-gu, Yongin, Republic of Korea.
Republic of Korea.
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Adenophora triphylla (A. triphylla) var. japonica (Korean
name: Jan-dae, Japanese name: lady bell, English name: Three-
leaf ladybell) belongs to the Adenophora species (Campanula-
ceae), which has been used as an oriental medicinal plant in
Korea, China and Japan for anti-inﬂammation, anti-tussive [1]
and hepatoprotective effects. Alkaloids, triterpenoids and
essential oil components such as pyrrolidine, piperidine,
triphyllol, nonacosane, heptacosane, lupenone and saponine
have been identiﬁed from A. triphylla. These chemicals have
anti-inﬂammatory and anti-oxidant properties, and are used to
prevent obesity in Korea.
Obesity has become a signiﬁcant clinical problem in recent
decades since it could contribute to life-threatening diseases
such as type 2 diabetes, hypertension, hyperlipidemia, and car-
diovascular disease [2]. It is characterized by increased fat mass,
which is associated with increased cell number (hyperplasia) and
sizes (hypertrophy) [3,4]. Adipocyte hypertrophy is caused by
excessive accumulation of lipid such as triglyceride formed
from energy intake [5]. Adipocytes hyperplasia results from a
complex interaction between proliferation and differentiation
in preadipocytes that is involved in the adipogenic process
where undifferentiated preadipocytes are converted to
differentiated adipocytes [6,7]. Therefore, adipogenesis and TG
accumulation play an important role in fat mass increase.
Accordingly, controlling adipogenesis and TG accumulation in
adipocytes could help prevent obesity and its associated
diseases.
There are many different pharmacological approaches to
prevent and treat obesity, but they reportedly have a number of
limitations such as undesirable side effects and adverse effects
[8,9]. Recently, there is increasing public attention on using
natural products to prevent and treat obesity with various
plants such as fruits, vegetables, and herbs that have beneﬁcial
health effects and minimal side effects [10].
A. triphylla root extracts have anti-obesity and hypo-
lipidemia effects [11,12], however, A. triphylla var. japonica
have not yet been studied in adipocytes and high-fat diet
(HFD)-induced obese mice related adipogenesis and
lipogenesis mechanisms.
In the present study, we examined the effect of A. triphylla
var. japonica extracts (ATE) on obesity and the underlying lipid
mechanisms, lipid deposition and lipogenesis, in adipocytes and
HFD-induced obese mice.
2. Materials and methods
2.1. Chemicals and reagents
50-diallyl-2, 20-biphenyldiol, 3-isobutylmethylxanthine, in-
sulin, and dexamethasone were purchased from Wako Pure
Chemical Industries Ltd. (Osaka, Japan). Oil-Red O, iso-
propanol, and TRI reagent were purchased from Sigma–Aldrich
(MO, USA). Polyclonal antibodies against peroxisome
proliferator-activated receptor g (PPARg), aP2, and a-tubulin
were purchased from Santa Cruz Biotechnology (CA, USA).
Horseradish peroxidase-linked anti-rabbit IgG and HRP-linked
anti-mouse IgG were purchased from Bio-Rad (CA, USA).
SYBR Green reaction buffer was purchased from Takara (Shiga,
Japan).2.2. Preparation and component analysis of ATE
A. triphylla var. japonica was provided from DONG IL
Pharmtec (Seoul, Korea). The dried A. triphylla var. japonica
was extracted with 70% aqueous ethyl alcohol and subjected to
vacuum evaporation. Gas chromatography was carried out with
an Agilent 7890A GC-FID instrument for the analysis of linoleic
acid as a reference compound. GC conditions were equipped on
HP-INNOWAX (30 m × 0.25 mm × 0.25 mm) column. The GC
oven temperature was maintained at 80 C for 3 min and
increased to 260 C with helium as a carrier gas at a ﬂow rate of
1.0 mL/min, and. Both injector and detector were set at 260 C
and 290 C. The total analysis time was 25 min.
2.3. Animal studies
Male C57BL/6J mice were purchased from Samtaco
(Gyeonggi-do, Korea) at 4 wk of age. The mice were housed
individually in stainless steel cages and maintained under a
temperature of (23 ± 3) C in a humidity-controlled room with a
12 h-light/dark cycle. Mice were given free access to water and
food (Certiﬁed irradiated global 18% protein diet, 2918C, Har-
lan Laboratories, Inc., Indianapolis, Indiana, USA). After
acclimatization for 1 wk, they were fed with either the normal-
fat diet (NFD, n = 8, Rodent diet with 10% kcal fat, D12450B)
or HFD (n = 32, Rodent diet with 60% kcal fat, D12492) pur-
chased from Research Diet Inc., (New Brunswick, NJ, USA) for
4 wk to induce obesity. After obesity induction, the mice were
divided into 4 subgroups (n = 8/group) that were matched with
body weight. The following 4 groups were studied for 6 wk:
HFD; HFD with oral administration of ATE at 100 mg/kg of
body weight (HFD + ATE 100); HFD with ATE at 200 mg/kg of
body weight (HFD + ATE 200); and HFD with ATE at 400 mg/
kg of body weight (HFD + ATE 400). The body weight of the
mice was measured once weekly for 6 wk. Food intake was
measured every 5 d on a per-cage basis throughout the study.
Food intake (g/mouse/day) was determined by subtracting the
remaining food weight from the initial food weight of the pre-
vious feeding day, and dividing by the number of mice housed
in the cage. At the end of the experiment, the mice were sacri-
ﬁced, and the liver, kidney, and white adipose tissue (WAT)
were excised immediately. The parts were then rinsed, weighed,
frozen in liquid N2, and stored at −80 C until analysis. The
experimental design was approved by The Animal Experiment
Committee of GyeongGi Bio Center, and the mice were main-
tained in accordance with their guidelines.
2.4. Plasma biochemical analysis
After 6 wk of feeding, 4 h-fasted mice were anesthetized
using ether and blood was collected. Plasma was obtained from
the blood by centrifugation at 800 g for 10 min at 4 C for
biochemical analyses of plasma parameters. The separated
plasma was stored at −80 C until analysis. Plasma total
cholesterol (T-CHO), TG, high-density lipoprotein (HDL)-
cholesterol, low-density lipoprotein (LDL)–cholesterol, and
glucose levels were determined enzymatically using commercial
assay kits (Asan Chemical, Seoul, Korea). Alanine aminotrans-
ferase (ALT) and aspartate aminotransferase (AST) were
measured using commercial assay kits (Sigma–Aldrich, MO,
USA).
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Histological examination of liver was conducted, and
epididymal adipose tissue were dissected and ﬁxed in 10%
neutral formalin solution and embedded in parafﬁn. The tissues
were studied under hematoxylin and eosin staining. The sections
were viewed with a light microscope (Olympus, Tokyo, Japan)
and photographed at ×200 magniﬁcation.
2.6. Cell culture
Mouse 3T3-L1 preadipocytes obtained from the Dr. Rhee,
Sang Dal (Korea Research Institute of Chemical Technology,
Daejeon, Korea), were cultured in Dulbecco's modiﬁed Eagle's
medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and antibiotics [100 U/mL penicillin and 100 g/mL
streptomycin (Gibco, Carlsbad, CA, USA)] at 37 C under a
humidiﬁed 5% CO2 atmosphere. For differentiation of 3T3-L1
preadipocytes to mature adipocytes, preconﬂuent cells (deﬁned
as day 0) were cultured in differentiation medium containing
0.5 mM 3-isobutylmethylxanthine, 5 mg/mL insulin, and 1 mM
dexamethasone in DMEM supplemented with 10% FBS (MDI
differentiation medium). After 3 d, the cell culture medium was
changed to DMEM containing 5 mg/mL insulin and 10% FBS.
The medium was replaced again with DMEM containing 10%
FBS after another 2 d. To determine the effect of ATE on adi-
pogenesis, differentiated preadipocytes were treated with pres-
ence or absence of ATE for 5 d.
2.7. Oil-red O staining
After differentiation, the cells were ﬁxed with 4% formal-
dehyde solution in phosphate-buffered saline for 1 h, and were
subsequently washed thrice with water. The cells were stained
with oil-red O (0.5% in 60% isopropanol) for 1 h and washed
thrice with distilled water. Stained cells were photographed
under an optical microscope (Olympus, Tokyo, Japan). Stained
lipid droplets were extracted with isopropanol and the absor-
bance was measured at 520 nm with a microplate reader (Tecan,
Mannedorf, Switzerland).
2.8. Cell cytotoxicity assay
For cell cytotoxicity, the cell were treated for 24 h with
various concentrations (0, 100, 300, and 500 mg/mL) of ATE
extracts in DMEM containing 10% FBS. Filtered MTT reagent
(5 mg/mL) was added to the cells to reach a ﬁnal concentration
of 0.5 mg MTT/mL, and the cells were further incubated for 4 h
at 37 C. The violet formazan crystals were dissolved in
dimethyl sulfoxide, and the absorbance was measured at 570 nm
by using a microplate reader. The cell viability (%) wasTable 1
Primer sequences used for quantitative real-time PCR.





SREBP-1c NM_011480 50-GGCACTAAGTGCCCcalculated by comparing the absorbance of the samples and the
control (untreated cell).
2.9. Protein extraction and Western blot analysis
Cold phosphate-buffered saline washed 3T3-L1 cells and
epididymal adipose tissue were homogenized in RIPA buffer
containing 0.1 mM phenylmethylsulfonyl ﬂuoride and 1% of
protease inhibitor cocktail (Sigma–Aldrich, MO, USA). The
homogenates were centrifuged at 12000 rpm for 15 min at 4 C,
and supernatant was collected. The protein concentrations were
calculated by Bio-Rad protein assay reagent (Bio-Rad Labora-
tories, Hercules, CA, USA). Proteins were separated by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
transferred to polyvinylidene diﬂuoride membranes (Bio-Rad
Laboratories, Hercules, CA, USA). The membranes were
blocked with 5% of nonfat dried skim milk and then incubated
with appropriate antibodies. The membranes were washed with
wash buffer and incubated with anti-mouse or anti-rabbit
horseradish peroxidase-conjugated secondary antibodies for
1 h. The immunoreactive bands were enhanced by chem-
iluminescence reagents and detected by chemi-luminometer
(CLINX Science Instruments Co., Ltd., Shanghai, China).
2.10. Isolation of total RNA and quantitative real-time
PCR (qRT-PCR)
Total RNA of epididymal adipose tissue was isolated by TRI
reagent (Sigma–Aldrich, MO, USA) according to the manufac-
turer's protocols. Total RNA was reverse transcribed to cDNA
by using random primers and a reverse transcription system
(Promega, Piscataway, NJ) according to manufacturer's recom-
mendations. The mRNA expression levels of adipogenesis-
related genes were analyzed by real-time PCR iQ™5 system
(Bio-Rad Laboratories, Hercules, CA, USA) using a SYBR
Green Master PCR Kit (Takara, Shiga, Japan) according to the
manufacturer's protocols. The real-time PCR cycling parameters
were as follows: 2 min at 95 C; 45 cycles of 20 s at 95 C, 20 s
at 60 C, 40 s at 72 C, and 30 s at 72 C; and a ﬁnal extension
for 5 min at 72 C, followed by a melting curve analysis. All
samples were normalized to the expression level of b-actin, and
the results were expressed as the fold changes relative to the
HFD group. The primers used in the experiments were listed in
Table 1.
2.11. Statistical analysis
Statistical evaluation of the data was expressed as the
mean ± standard error (SEM). The statistical signiﬁcance of
differences between the mean values for the treatment groups
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Software, USA). Values of P < 0.05 were considered as sta-
tistical signiﬁcance.
3. Results
3.1. Linoleic acid content of A. triphylla
The linoleic acid content in A. triphylla was elucidated by
comparing the chromatographic proﬁle of standard on gas
chromatography analysis. We conﬁrmed that linoleic acid con-
tent was approximately 2.0% (Figure 1), and the optimized
A. triphylla was used in all subsequent experiments.
3.2. Effects of ATE on adipogenesis of 3T3-L1
preadipocytes
To determine the effect of ATE on lipid accumulation during
differentiation, 3T3-L1 preadipocytes were induced to differ-
entiate into adipocytes in the presence of ATE for 5 d. Accu-
mulated lipid droplets were measured by Oil-Red O staining.
ATE inhibited the lipid accumulation in 3T3-L1 adipocytes
(Figure 2A); especially, 500 mg/mL ATE treatment signiﬁcantly
reduced the lipid content by 49.6%, as compared to the control
(P < 0.05) (Figure 2B). The cytotoxic effect of ATE on 3T3-L1
adipocytes was evaluated by the MTT assay. ATE had no
cytotoxic activity at various concentrations i.e., 100–500 mg/mL
for 24 h (Figure 2C). To investigate how ATE inhibits lipid
accumulation, we measured the expression levels of
adipogenesis-related proteins using Western blotting. As shownFigure 1. Gas chromatogram of linoleic acid from ATE.in Figure 2D, PPARg protein expression level decreased in 300
and 500 mg/mL of ATE treatment, as compared to the control.
Target proteins i.e., aP2 and fatty acid synthase (FAS) protein
expression level also decreased as compared to the control.
3.3. Effects of ATE on body weight and food intake
ATE inhibited lipid accumulation in 3T3-L1 cells. Based on
these results, we investigated the effect of ATE on anti-obesity
in HFD-induced obese mice. The body weight gain and food
intakes were shown in Figure 3. The body weight gain of the
HFD group was signiﬁcantly increased, as compared to the NFD
group after 6 wk of feeding; whereas administration of ATE at
100, 200, and 400 mg/kg showed a tendency to decrease body
weight gain than the HFD group (Figure 3A). Food intake did
not display signiﬁcant group wise differences (Figure 3B).
3.4. Effects of ATE on organs weight
The relative weight of liver, epididymal, perirenal, and
mesenteric WAT were compared to those in the HFD group
(Figure 4). Supplementation with ATE did not show signiﬁcant
differences in kidney weight in mice fed with HFD (Figure 4A).
However, the HFD plus ATE presented a decreased liver weight
when compared to the mice fed HFD (Figure 4B). Epididymal,
perirenal, mesenteric, and total WAT weights in the HFD group
were higher than those of the NFD group (Figure 4C). ATE
signiﬁcantly decreased epididymal, perirenal, mesentric, and
total WAT weights in HFD plus ATE 200 and 400 mg/kg fed
mice, respectively.
Figure 2. Effects of ATE on lipid accumulation.
(A) Lipid droplets were photographed after Oil-Red O staining. (B) The stained lipid content was quantiﬁed by measuring absorbance. Each percentage
value in treated cells was calculated with respect to control cells. (C) The cytotoxicity of 3T3-L1 cells was determined using MTT assay at 24 h and
expressed as a percentage of the optical density. (D) ATE-treated cells were subjected to Western blot analysis to determine the effects on adipogenesis-
related protein expression. *P < 0.05 and **P < 0.01, when compared to the control group.
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The plasma biochemical parameters were compared to the
HFD fed group. As shown in Table 2, glucose, T-CHO, and TG
levels in the HFD group were signiﬁcantly increased, as
compared to the ND fed mice group. In HFD plus ATE groups,
decreased HFD-induced plasma glucose, T-CHO; and TG levels
showed a propensity to decrease in a dose-dependent manner,
although not signiﬁcantly, as compare to the HFD group.
However, TG level in the HFD plus ATE 200 and 400 groups
were signiﬁcantly decreased, as compared to the HFD group.
HDL-cholesterol levels in HFD fed with ATE groups wereFigure 3. Effects of ATE on body weight gain and food intake rate in HFD-i
(A) Body weight gain. (B) Food intake rate. *P < 0.05 and **P < 0.01, whensigniﬁcantly increased, when compared to the HFD fed group.
There were no signiﬁcant differences in the LDL cholesterol
level, among the HFD and ATE-treated groups, but the ATE fed
groups presented a tendency towards decreased levels in. ALT
level in the HFD fed group was more signiﬁcantly increased
than that of the ND fed group. The HFD + ATE 200 and 400
groups exhibited tendency of decreased ALT, although there
were no statistically signiﬁcant differences, as compared to HFD
fed group. AST level in the NFD and HFD + ATE 100 group
did not differ, as compared to the HFD group, but showed a
signiﬁcant reduction in HFD fed with 200 and 400 mg/kg of
ATE groups.nduced obese mice for 6 wk.
compared to the HFD group (n = 8 per group).
Figure 4. Effects of ATE on organ weights in HFD-induced obese mice during 6 wk.
(A) Liver weight. (B) Kidney weight. (C) WATs weight. WAT: white adipose tissue. *P < 0.05 and **P < 0.01, when compared to the HFD group (n = 8 per
group).
Table 2
Effects of ATE on plasma biochemical parameters in HFD-induced obese mice.
Indexes ND HFD HFD + ATE 100 HFD + ATE 200 HFD + ATE 400
Glucose (mg/dL) 164.21 ± 15.00* 264.71 ± 16.72 248.39 ± 11.37 248.81 ± 8.06 238.70 ± 4.75
T-CHO (mg/dL) 135.63 ± 5.51* 184.14 ± 9.03 177.80 ± 5.05 172.80 ± 9.00 169.33 ± 7.59
TG (mg/dL) 66.78 ± 3.57* 78.67 ± 3.55 72.75 ± 2.71 68.75 ± 0.86* 64.56 ± 3.02**
LDL (mg/dL) 37.14 ± 5.35 46.43 ± 3.30 42.00 ± 3.12 43.17 ± 1.96 41.14 ± 2.46
HDL (mg/dL) 83.59 ± 5.33** 130.21 ± 6.09 132.52 ± 4.07 130.25 ± 5.29 129.21 ± 5.10
ALT (U/L) 37.79 ± 4.10 50.29 ± 4.82 44.70 ± 7.00 39.06 ± 2.72 36.20 ± 2.62
AST (U/L) 61.61 ± 3.33 71.58 ± 3.88 70.20 ± 5.64 59.84 ± 1.02* 57.37 ± 2.15**
The data are presented as means ± SEM. *P < 0.05 and **P < 0.01 and, when compared to the HFD group (n = 8 per group).
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tissue morphology
Histological observations of liver and epididymal adipose
tissue were conducted through 5 groups as follows: NFD; HFD;
HFD + ATE 100, 200, and 400 groups (Figure 5). Sections of
liver and epididymal adipose tissue were stained with hema-
toxylin and eosin to examine the lipid accumulations and
cellular morphology. In WAT, adipocytes size of the HFD group
showed an increase, as compared to the NFD group; however,
adipocytes size of the HFD + ATE 200 and 400 groups were
reduced, as compared to the HFD group. In the liver, lipid
droplet sizes of the HFD group were larger than that of the NFD
group; however, ATE treatment decreased the lipid droplet size,
in a dose-dependent manner.
3.7. Effects of ATE on expression levels of adipogenesis-
related genes and proteins
Of the adipogenesis-related protein expression levels in ATE-
treated 3T3-L1 adipocytes, we found that PPARg, aP2, and FASprotein expression levels were decreased in a dose-dependent
manner. We determined whether ATE affects the protein
expression of adipogenesis-related genes and protein in epidid-
ymal adipose tissues of HFD-induced obese mice, using the
quantitative real-time PCR and Western blot. As shown in
Figure 6A, PPARg, aP2, FAS, sterol regulatory element binding
protein-1c (SREBP-1c), and LPL mRNA expression levels in the
HFD fed group were increased than those of the NFD fed group,
but the difference was not statistically signiﬁcant. However, the
mRNA expression level was signiﬁcantly decreased in the HFD
plus ATE groups, as compared to the HFD group. SREBP-1c
and FAS mRNA expression level in the HFD group was
signiﬁcantly increased, as compared to the NFD group, whereas
SREBP-1c mRNA expression level signiﬁcantly decreased in 3
ATE-treated groups. FAS mRNA expression level showed a
tendency of decrease, and was signiﬁcantly decreased in the
HFD plus 400 mg/kg ATE group, as compared to the HFD
group. Additionally, ATE treatments increased LPL mRNA
level, in a dose-dependent manner. Consistently, PPARg protein
expression level in the HFD plus ATE groups was decreased in a
dose-dependent manner, and it especially showed statically
Figure 5. Histological observations of liver section and epididymal adipose tissue.
(A) Epididymal adipose tissue and (B) liver were stained with hematoxylin and eosin, and were viewed under a microscope (×200). Representative sections
are from 3 mice of each treated group.
Figure 6. Effects of ATE on expression level of adipogenesis-related genes and protein in epididymal adipose tissues from 8 mice.
(A) The mRNA expressions level of adipogenesis-related genes was evaluated by quantitative real-time PCR. (B) PPARg protein expression level was
detected by Western blot analysis. *P < 0.05 and **P < 0.01, when compared to the HFD group (n = 8 per group).
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(Figure 6B).
4. Discussion
Long-chain polyunsaturated fatty acid, linoleic acid, has less
known effects when derived from plants, especially from roots
of A. triphylla [14]. Polyunsaturated fatty acid is a potent
compound with biological responses that are required for
health. In the present study, we demonstrated the 18-carbon
polyunsaturated fatty acid, linoleic acid (LA, 18:2n−6, theprecursor of arachidonic acid) as a reference compound by gas
chromatography analysis with 2% from ATE. Linoleic acid is an
essential fatty acid that is synthesized in the human body as an
unsaturated fatty acid for membrane phospholipids. Recent
publications have shown that linoleic acid has anti-bacterial [15],
anti-oxidative [16], anti-inﬂammatory [17] activities and
attenuates the development of obesity-related pathogenesis,
such as insulin resistance [18,19].
Recently, several studies showed that A. triphylla has com-
pounds including saponine, b-sitosterol, cycloartenyl acetate,
and taraxenone [11,13]. It has been reported that ATE and isolated
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tumor effects. Based on these results, the present study
conﬁrmed an anti-obesity effect including lipid synthesis of ATE
and elucidated the mechanisms underlying such effects in 3T3-
L1 adipocytes and HFD-induced obese mice.
Our results demonstrated that ATE treatment dose-
dependently inhibited the differentiation and lipid accumula-
tion in 3T3-L1 adipocytes. This result was further supported by
in vivo experiment, demonstrating that ATE treatment for 6 wk
signiﬁcantly reduced the body weight gain in HFD-induced
obese mice. These results are in accordance with previous re-
ports that A. triphylla root ethanol extract has anti-obesity effects
[11,12]. Additionally, ATE treatment did not affect the food
intake in HFD-induced obese mice. These results suggested
that ATE treatment has anti-obesity effects, and reduction in
weight gain induced by ATE treatment is related to decreasing
food efﬁciency and not decreasing food intake.
Obesity is characterized by adipose tissue remodeling asso-
ciated with hyperplasia and hypertrophy [20,21]. Adipocytes
hypertrophy is caused by an excessive accumulation of TG
from the intake of excess energy, and it results from an energy
imbalance. Since adipocytes hyperplasia results from a
complex interaction between proliferation and differentiation
in preadipocytes [22]. It is examined by 3T3-L1 adipocytes dif-
ferentiation system. To differentiate from preadipocytes into
adipocytes, proliferation of preadipocytes is a prerequisite [23].
Adipogenic signals MDI differentiation medium, initiating the
differentiation after mitotic clonal expansion [24]. It has been
suggested that inhibition of proliferation may be the potential
mechanism for reducing the adipocytes number [25]. We
conﬁrmed that ATE treatment inhibited lipid accumulation
during differentiation in 3T3-L1 adipocytes without cytotox-
icity. Also, ATE with HFD fed mice exhibited the tendency to
decrease the epididymal, perirenal, and total WAT weights in
HFD-induced obese mice. Moreover, histological data showed a
decrease in the adipocytes size of adipose tissue in ATE-treated
mice. These results indicated that ATE treatment may affect both
the cell number and sizes of adipocytes in adipose tissue, which
is likely to be associated with reduced WATs weight. However,
cell proliferation and cell cycle need to be further investigated.
Fatty liver results from increased free fatty acid uptake and
endogenous hepatic fatty acid synthesis [26]. Histological data of
liver revealed that ATE treatment reduced lipid droplet size and
number, indicating that ATE treatment was responsible for the
inhibition of lipid accumulation in liver. In our study, ATE
treatment lowered plasma TG level, while 100 and 200 mg/kg
ATE treatment increased plasma HDL-cholesterol level in
HFD-induced obese mice, as shown in previous reports [11,12].
These results collectively suggest that ATE treatment reduces
the accumulation in liver, resulting in the improved
hyperlipidemia in HFD-induced obese mice.
Excessive fat intake can cause the oxidative stress, which
induces dysfunction and fatty degeneration in the liver through
abnormal activation of AST and ALT. Previous reports have
demonstrated that various extracts of A. triphylla have an anti-
oxidant effect that reduces plasma ALT and AST levels in HFD-
induced obese mice [11,12]. In our study, 200 and 400 mg/kg
ATE treatment showed a tendency to decrease plasma ALT
and AST levels in HFD-induced obese mice, as compared to
the HFD group. These results showed that ATE treatment may
improve the liver function.To examine the underlying mechanism, we measured the
expression levels of adipogenesis-related genes and proteins in
3T3-L1 adipocytes and WAT in HFD-induced obese mice.
Adipogenesis is closely associated with etiologies of obesity, in
which the preadipocytes are differentiated into mature adipo-
cytes. Adipogenesis is regulated by sequential expression of
adipogenic and lipogenic genes [27]. PPARg is a transcription
factor that regulates adipocytes differentiation and
adipogenesis. C/EBPa promotes adipocytes differentiation
through cooperation with PPARg, which increases the
expression of adipocytes-speciﬁc genes such as aP2 [28,29].
SREBP-1c is also a transcription factor that plays key roles in
lipid metabolism, by increasing the expressions of several
lipogenic genes such as FAS in adipose tissue and liver. It
activates PPARg through regulation of its expression and
production of an endogenous PPARg ligand [30,31]. The
lipoprotein lipase is a key regulator of blood TG levels via
decomposition of lipoprotein triglyceride. It plays a critical
roles in transporting the fats and hydrolysis fat-carried lipopro-
teins [32]. Combined action of these transcription factors causes
expression of target genes and proteins that are responsible for
TG synthesis and storage, which leads to accelerated
adipogenesis. We found that the high concentration of ATE
treatment reduced the PAPRg, C/EBPa, aP2, and FAS protein
expression level in 3T3-L1 adipocytes. Furthermore, PAPRg
and SREBP-1c mRNA expression level were signiﬁcantly
decreased in epididymal adipose tissue of 100, 200, and 400 mg/
kg ATE-treated mice. Additionally, aP2 and FAS mRNA
expression level was decreased in 400 mg/kg ATE-treated mice.
PPARg protein expression levels tended to be reduced specif-
ically in adipose tissues of HFD fed with ATE groups, and
signiﬁcant down-regulation was observed in the 200 and
400 mg/kg ATE treatment groups. On the other hand, the
reduction in body weight gain and total WATs weight were
unfortunately not observed in the 100 mg/kg of ATE treatment
group, despite the down-regulation of adipogenesis-related
genes. There is a possibility that there are differences in
PPARg protein expression levels in ATE-treated groups. How-
ever, more study is needed on the expression levels of other
genes related to adipogenesis in adipose and other tissues. Based
on our results, ATE treatment affects the expression levels of
adipogenesis-related genes and proteins. Furthermore, it is likely
that the anti-obesity effects of ATE treatment are caused by
suppression of gene expressions and proteins involved in
adipogenesis.
In conclusion, our results showed that ATE treatment
inhibited the lipid accumulation in 3T3-L1 adipocytes and
reduced the body weight gain, WATs weight, adipocytes sizes,
and plasma TG levels, without any toxic effects in HFD-induced
obese mice. These effects were at least partially accompanied by
the regulation of gene expressions and proteins associated with
adipogenesis/lipogenesis, in 3T3-L1 adipocytes and HFD-
induced obese mice. These ﬁndings indicated that ATE pre-
vents the development of obesity and hyperlipidemia in 3T3-L1
adipocytes and HFD-induced obese mice, which suggest the
possibility of its use for the prevention of obesity and obesity-
related diseases.
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